Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Head Neck. 2019 Jan 11;41(6):1952–1960. doi: 10.1002/hed.25650

Fig. 1.

Fig. 1

Overall survival and recurrence for typical onset (blue) and early onset (red) OTC. Figure 1(a) shows a significantly improved overall survival (p = 0.046) for patients with early onset OTC. Figure 1(b) shows no difference in OTC recurrence between patients with typical and early onset OTC.